Stockreport

FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study

MacroGenics, Inc.  (MGNX) 
Last macrogenics, inc. earnings: 11/6 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.macrogenics.com
PDF • Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers   • On track to provide mid-2026 program update  ROCKVILLE, MD, April 08, 2026 ( [Read more]